CRISPR-Cas9 System as a Versatile Tool for Genome Engineering in Human Cells

Molecular Therapy Nucleic Acids

Volumn 5, Issue , 2016, Pages e388-

  Wang, Xuelian ^a,b   Huang, Xiumin ^a   Fang, Xiuli ^a   Zhang, Youzhong ^b   Wang, Wanpeng ^c  

^a ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c SOA Fujian Collaborative Innovation Center for Exploitation and Utilization of Marine Biological Resources Key Laboratory of Marine Genetic   (China)

Author keywords

Cas9; CRISPR; crRNA; genome editing; human cells; RGEN

Indexed keywords

COMPARATIVE STUDY; CRISPR CAS SYSTEM; GENE CONTROL; GENE EDITING; GENE INACTIVATION; GENE TARGETING; GENE THERAPY; GENETIC ENGINEERING; GENETIC SCREENING; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; HUMAN GENOME; MOLECULARLY TARGETED THERAPY; NONHUMAN; PRIORITY JOURNAL; REVIEW; CELL ENGINEERING; HIGH THROUGHPUT SCREENING; TRANSCRIPTION REGULATION;

EID: 85015193298     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2016.95     Document Type: Review

References (67)

1. 1 Bhaya, D, Davison, M, Barrangou, R, CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation. Annu Rev Genet 45 (2011), 273–297.
2. 2 Makarova, KS, Haft, DH, Barrangou, R, Brouns, SJ, Charpentier, E, Horvath, P, et al. Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol 9 (2011), 467–477.
3. 3 Deltcheva, E, Chylinski, K, Sharma, CM, Gonzales, K, Chao, Y, Pirzada, ZA, et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471 (2011), 602–607.
4. 4 Esvelt, KM, Mali, P, Braff, JL, Moosburner, M, Yaung, SJ, Church, GM, Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods 10 (2013), 1116–1121.
5. 5 Karvelis, T, Gasiunas, G, Miksys, A, Barrangou, R, Horvath, P, Siksnys, V, crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus. RNA Biol 10 (2013), 841–851.
6. 6 Gasiunas, G., Barrangou, R., Horvath, P., Siksnys, V., Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proceedings of the National Academy of Sciences 109 (2012), E2579–E2586.
7. 7 Horvath, P, Romero, DA, Coûté-Monvoisin, AC, Richards, M, Deveau, H, Moineau, S, et al. Diversity, activity, and evolution of CRISPR loci in Streptococcus thermophilus. J Bacteriol 190 (2008), 1401–1412.
8. 8 Zhang, Y, Heidrich, N, Ampattu, BJ, Gunderson, CW, Seifert, HS, Schoen, C, et al. Processing-independent CRISPR RNAs limit natural transformation in Neisseria meningitidis. Mol Cell 50 (2013), 488–503.
9. 9 Sorek, R, Lawrence, CM, Wiedenheft, B, CRISPR-mediated adaptive immune systems in bacteria and archaea. Annu Rev Biochem 82 (2013), 237–266.
10. 10 Jinek, M, Chylinski, K, Fonfara, I, Hauer, M, Doudna, JA, Charpentier, E, A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337 (2012), 816–821.
11. 11 Garneau, JE, Dupuis, MÈ, Villion, M, Romero, DA, Barrangou, R, Boyaval, P, et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468 (2010), 67–71.
12. 12 Li, JF, Norville, JE, Aach, J, McCormack, M, Zhang, D, Bush, J, et al. Multiplex and homologous recombination-mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9. Nat Biotechnol 31 (2013), 688–691.
13. 13 DiCarlo, JE, Norville, JE, Mali, P, Rios, X, Aach, J, Church, GM, Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res 41 (2013), 4336–4343.
14. 14 Cho, SW, Kim, S, Kim, JM, Kim, JS, Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol 31 (2013), 230–232.
15. 15 Cong, L, Ran, FA, Cox, D, Lin, S, Barretto, R, Habib, N, et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339 (2013), 819–823.
16. 16 Xie, K, Yang, Y, RNA-guided genome editing in plants using a CRISPR-Cas system. Mol Plant 6 (2013), 1975–1983.
17. 17 Hwang, WY, Fu, Y, Reyon, D, Maeder, ML, Tsai, SQ, Sander, JD, et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 31 (2013), 227–229.
18. 18 Gratz, SJ, Cummings, AM, Nguyen, JN, Hamm, DC, Donohue, LK, Harrison, MM, et al. Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics 194 (2013), 1029–1035.
19. 19 Chang, N, Sun, C, Gao, L, Zhu, D, Xu, X, Zhu, X, et al. Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res 23 (2013), 465–472.
20. 20 Jiang, W, Bikard, D, Cox, D, Zhang, F, Marraffini, LA, RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol 31 (2013), 233–239.
21. 21 Qi, LS, Larson, MH, Gilbert, LA, Doudna, JA, Weissman, JS, Arkin, AP, et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152 (2013), 1173–1183.
22. 22 Bikard, D, Jiang, W, Samai, P, Hochschild, A, Zhang, F, Marraffini, LA, Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res 41 (2013), 7429–7437.
23. 23 Jinek, M, East, A, Cheng, A, Lin, S, Ma, E, Doudna, J, RNA-programmed genome editing in human cells. Elife, 2, 2013, e00471.
24. 24 Ding, Q, Regan, SN, Xia, Y, Oostrom, LA, Cowan, CA, Musunuru, K, Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell 12 (2013), 393–394.
25. 25 Anders, C, Niewoehner, O, Duerst, A, Jinek, M, Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature 513 (2014), 569–573.
26. 26 Xu, T, Li, Y, Van Nostrand, JD, He, Z, Zhou, J, Cas9-based tools for targeted genome editing and transcriptional control. Appl Environ Microbiol, 2014, 1544–1552.
27. 27 Yang, H, Wang, H, Shivalila, CS, Cheng, AW, Shi, L, Jaenisch, R, One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154 (2013), 1370–1379.
28. 28 Mali, P, Yang, L, Esvelt, KM, Aach, J, Guell, M, DiCarlo, JE, et al. RNA-guided human genome engineering via Cas9. Science 339 (2013), 823–826.
29. 29 Shen, B, Zhang, J, Wu, H, Wang, J, Ma, K, Li, Z, et al. Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. Cell Res 23 (2013), 720–723.
30. 30 Friedland, AE, Tzur, YB, Esvelt, KM, Colaiácovo, MP, Church, GM, Calarco, JA, Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat Methods 10 (2013), 741–743.
31. 31 Li, D, Qiu, Z, Shao, Y, Chen, Y, Guan, Y, Liu, M, et al. Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. Nat Biotechnol 31 (2013), 681–683.
32. 32 Li, W, Teng, F, Li, T, Zhou, Q, Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nat Biotechnol 31 (2013), 684–686.
33. 33 Wyman, C, Kanaar, R, DNA double-strand break repair: all's well that ends well. Annu Rev Genet 40 (2006), 363–383.
34. 34 Smith, GR, Homologous recombination near and far from DNA breaks: alternative roles and contrasting views. Annu Rev Genet 35 (2001), 243–274.
35. 35 Shuman, S, Glickman, MS, Bacterial DNA repair by non-homologous end joining. Nat Rev Microbiol 5 (2007), 852–861.
36. 36 Hou, Z, Zhang, Y, Propson, NE, Howden, SE, Chu, LF, Sontheimer, EJ, et al. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proceedings of the National Academy of Sciences 110 (2013), 15644–15649.
37. 37 Ran, FA, Hsu, PD, Lin, CY, Gootenberg, JS, Konermann, S, Trevino, AE, et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154 (2013), 1380–1389.
38. 38 Mali, P, Aach, J, Stranges, PB, Esvelt, KM, Moosburner, M, Kosuri, S, et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol 31 (2013), 833–838.
39. 39 Dianov, GL, Hübscher, U, Mammalian base excision repair: the forgotten archangel. Nucleic Acids Res 41 (2013), 3483–3490.
40. 40 Wilson, RC, Doudna, JA, Molecular mechanisms of RNA interference. Annu Rev Biophys 42 (2013), 217–239.
41. 41 Shalem, O, Sanjana, NE, Hartenian, E, Shi, X, Scott, DA, Mikkelsen, TS, et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343 (2014), 84–87.
42. 42 Wang, T, Wei, JJ, Sabatini, DM, Lander, ES, Genetic screens in human cells using the CRISPR-Cas9 system. Science 343 (2014), 80–84.
43. 43 Zhou, Y, Zhu, S, Cai, C, Yuan, P, Li, C, Huang, Y, et al. High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature 509 (2014), 487–491.
44. 44 Miller, JC, Holmes, MC, Wang, J, Guschin, DY, Lee, YL, Rupniewski, I, et al. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol 25 (2007), 778–785.
45. 45 Porteus, MH, Baltimore, D, Chimeric nucleases stimulate gene targeting in human cells. Science, 300, 2003, 763.
46. 46 Sander, JD, Dahlborg, EJ, Goodwin, MJ, Cade, L, Zhang, F, Cifuentes, D, et al. Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA). Nat Methods 8 (2011), 67–69.
47. 47 Wood, AJ, Lo, TW, Zeitler, B, Pickle, CS, Ralston, EJ, Lee, AH, et al. Targeted genome editing across species using ZFNs and TALENs. Science, 333, 2011, 307.
48. 48 Christian, M, Cermak, T, Doyle, EL, Schmidt, C, Zhang, F, Hummel, A, et al. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186 (2010), 757–761.
49. 49 Zhang, F, Cong, L, Lodato, S, Kosuri, S, Church, GM, Arlotta, P, Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol 29 (2011), 149–153.
50. 50 Hockemeyer, D, Wang, H, Kiani, S, Lai, CS, Gao, Q, Cassady, JP, et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 29 (2011), 731–734.
51. 51 Reyon, D, Tsai, SQ, Khayter, C, Foden, JA, Sander, JD, Joung, JK, FLASH assembly of TALENs for high-throughput genome editing. Nat Biotechnol 30 (2012), 460–465.
52. 52 Kim, Y, Kweon, J, Kim, A, Chon, JK, Yoo, JY, Kim, HJ, et al. A library of TAL effector nucleases spanning the human genome. Nature Biotechnol 31 (2013), 251–252.
53. 53 Ramalingam, S, Annaluru, N, Chandrasegaran, S, A CRISPR way to engineer the human genome. Genome Biol, 14, 2013, 107.
54. 54 Mercer, AC, Gaj, T, Fuller, RP, Barbas, CF 3rd, Chimeric TALE recombinases with programmable DNA sequence specificity. Nucleic Acids Res 40 (2012), 11163–11172.
55. 55 Gaj, T, Mercer, AC, Gersbach, CA, Gordley, RM, Barbas, CF, Structure-guided reprogramming of serine recombinase DNA sequence specificity. Proceedings of the National Academy of Sciences 108 (2011), 498–503.
56. 56 Yant, SR, Huang, Y, Akache, B, Kay, MA, Site-directed transposon integration in human cells. Nucleic Acids Res, 35, 2007, e50.
57. 57 Xiao, A, Wang, Z, Hu, Y, Wu, Y, Luo, Z, Yang, Z, et al. Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish. Nucleic Acids Res, 41, 2013, e141.
58. 58 Mali, P, Esvelt, KM, Church, GM, Cas9 as a versatile tool for engineering biology. Nat Methods 10 (2013), 957–963.
59. 59 Urnov, FD, Miller, JC, Lee, YL, Beausejour, CM, Rock, JM, Augustus, S, et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435 (2005), 646–651.
60. 60 Lombardo, A, Genovese, P, Beausejour, CM, Colleoni, S, Lee, YL, Kim, KA, et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol 25 (2007), 1298–1306.
61. 61 Li, H, Haurigot, V, Doyon, Y, Li, T, Wong, SY, Bhagwat, AS, et al. In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature 475 (2011), 217–221.
62. 62 Verma, IM, Somia, N, Gene therapy – promises, problems and prospects. Nature 389 (1997), 239–242.
63. 63 Grieger, JC, Samulski, RJ., Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. InGene Therapy and Gene Delivery Systems, 2005, Springer, Berlin, Heidelberg, 119–145.
64. 64 Miyoshi, H, Takahashi, M, Gage, FH, Verma, IM, Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proceed Natl Acad Sci USA 94 (1997), 10319–10323.
65. 65 Yeh, P, Perricaudet, M, Advances in adenoviral vectors: from genetic engineering to their biology. FASEB J 11 (1997), 615–623.
66. 66 Riechmann, L, Clark, M, Waldmann, H, Winter, G, Reshaping human antibodies for therapy. Nature 332 (1988), 323–327.
67. 67 Randow, F, MacMicking, JD, James, LC, Cellular self-defense: how cell-autonomous immunity protects against pathogens. Science 340 (2013), 701–706.